Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Padraig Warde

Showing results (81-90 of 174) with videos related to

Pageof 18
Sort By:
International Journal of Radiation Oncology, Biology, Physics|March 15, 2020
A Cost-Utility Analysis of Magnetic Resonance (MR) Guided Brachytherapy Versus Two-Dimensional and Computed Tomography (CT) Guided Brachytherapy for Locally Advanced Cervical CancerJohnna Perdrizet, David D'Souza, Julia Skliarenko, et al.
JAMA Network Open|July 2, 2021
Association of Chemotherapy, Enzalutamide, Abiraterone, and Radium 223 With Cognitive Function in Older Men With Metastatic Castration-Resistant Prostate CancerShabbir M H Alibhai, Henriette Breunis, Gregory Feng, et al.
Cancer Research|July 10, 2007
Androgen withdrawal in patients reduces prostate cancer hypoxia: implications for disease progression and radiation responseMichael Milosevic, Peter Chung, Chris Parker, et al.
International Journal of Radiation Oncology, Biology, Physics|April 12, 2011
Role of principal component analysis in predicting toxicity in prostate cancer patients treated with hypofractionated intensity-modulated radiation therapyDanny Vesprini, Michael Sia, Gina Lockwood, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|November 23, 2021
Trimodal therapy vs. radical cystectomy for muscle-invasive bladder cancer: A Markov microsimulation modelDiana Magee, Douglas Cheung, Amanda Hird, et al.
Cancer|March 27, 2015
Long-term impact of androgen-deprivation therapy on physical function and quality of lifeShabbir M H Alibhai, Henriette Breunis, Narhari Timilshina, et al.
Urology Practice|April 27, 2023
Cost of Bladder Cancer Care: A Single-center Comparison of Radical Cystectomy and Trimodal TherapyDiana E Magee, Douglas C Cheung, Amanda E Hird, et al.
International Journal of Radiation Oncology, Biology, Physics|July 4, 2007
Phase II trial of hypofractionated image-guided intensity-modulated radiotherapy for localized prostate adenocarcinomaJarad M Martin, Tara Rosewall, Andrew Bayley, et al.
Technical Innovations & Patient Support in Radiation Oncology|September 15, 2022
Impact of intrafraction changes in delivered dose of the day for prostate cancer patients treated with stereotactic body radiotherapy via MR-LinacJennifer Dang, Vickie Kong, Winnie Li, et al.
Technical Innovations & Patient Support in Radiation Oncology|March 7, 2022
Dosimetric comparison of MR-guided adaptive IMRT versus 3DOF-VMAT for prostate stereotactic radiotherapyVickie C Kong, Jennifer Dang, Winnie Li, et al.
Pageof 18

Showing results (81-90 of 174) with videos related to

Sort By:
Pageof 18
International Journal of Radiation Oncology, Biology, Physics|March 15, 2020
A Cost-Utility Analysis of Magnetic Resonance (MR) Guided Brachytherapy Versus Two-Dimensional and Computed Tomography (CT) Guided Brachytherapy for Locally Advanced Cervical CancerJohnna Perdrizet, David D'Souza, Julia Skliarenko, et al.
JAMA Network Open|July 2, 2021
Association of Chemotherapy, Enzalutamide, Abiraterone, and Radium 223 With Cognitive Function in Older Men With Metastatic Castration-Resistant Prostate CancerShabbir M H Alibhai, Henriette Breunis, Gregory Feng, et al.
Cancer Research|July 10, 2007
Androgen withdrawal in patients reduces prostate cancer hypoxia: implications for disease progression and radiation responseMichael Milosevic, Peter Chung, Chris Parker, et al.
International Journal of Radiation Oncology, Biology, Physics|April 12, 2011
Role of principal component analysis in predicting toxicity in prostate cancer patients treated with hypofractionated intensity-modulated radiation therapyDanny Vesprini, Michael Sia, Gina Lockwood, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|November 23, 2021
Trimodal therapy vs. radical cystectomy for muscle-invasive bladder cancer: A Markov microsimulation modelDiana Magee, Douglas Cheung, Amanda Hird, et al.
Cancer|March 27, 2015
Long-term impact of androgen-deprivation therapy on physical function and quality of lifeShabbir M H Alibhai, Henriette Breunis, Narhari Timilshina, et al.
Urology Practice|April 27, 2023
Cost of Bladder Cancer Care: A Single-center Comparison of Radical Cystectomy and Trimodal TherapyDiana E Magee, Douglas C Cheung, Amanda E Hird, et al.
International Journal of Radiation Oncology, Biology, Physics|July 4, 2007
Phase II trial of hypofractionated image-guided intensity-modulated radiotherapy for localized prostate adenocarcinomaJarad M Martin, Tara Rosewall, Andrew Bayley, et al.
Technical Innovations & Patient Support in Radiation Oncology|September 15, 2022
Impact of intrafraction changes in delivered dose of the day for prostate cancer patients treated with stereotactic body radiotherapy via MR-LinacJennifer Dang, Vickie Kong, Winnie Li, et al.
Technical Innovations & Patient Support in Radiation Oncology|March 7, 2022
Dosimetric comparison of MR-guided adaptive IMRT versus 3DOF-VMAT for prostate stereotactic radiotherapyVickie C Kong, Jennifer Dang, Winnie Li, et al.
Pageof 18